At Daiichi Sankyo, we create essential medicine for longer, better lives. By uniting cutting edge science and technology with a genuine interest in people, we develop high quality, life changing solutions for the patients of today and tomorrow with great care and unwavering dedication. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need. For more information, please visit www.daiichisankyo.us. See our community guidelines here: https://bit.ly/3PYTqYr

Our vision is to build Calvin Klein and TOMMY HILFIGER into the most desirable lifestyle brands in the world, and make PVH one of the highest performing brand groups in our sector.

Ralph Lauren Corporation (NYSE:RL) is a global leader in the design, marketing and distribution of luxury lifestyle products in five categories: apparel, footwear & accessories, home, fragrances and hospitality. For more than 50 years, Ralph Lauren has sought to inspire the dream of a better life through authenticity and timeless style. Its reputation and distinctive image have been developed across a wide range of products, brands, distribution channels and international markets. The Company’s brand names – which include Ralph Lauren, Ralph Lauren Collection, Ralph Lauren Purple Label, Polo Ralph Lauren, Double RL, Lauren Ralph Lauren, Polo Ralph Lauren Children and Chaps, among others – constitute one of the world’s most widely recognized families of consumer brands.

Breakthru Beverage is a family-owned and operated company with operations across the U.S. and Canada, and more than $8 billion in annual sales driven by a team of 10,000 associates. We deliver world-renowned brands to the doorsteps of North America’s retail, bar and restaurant businesses. Our sales and logistics expertise stems from two industry pioneers, Charmer Sunbelt Group and Wirtz Beverage Group. Breakthru Beverage Group was formed in 2016 when these two longtime leading beverage companies joined forces.

Imperial Paper Company provides packaging supplies and expertise in packaging design. Since 1983 we have successfully delivered high quality innovative packaging solutions to clients accross many industries. We provide an essential ingredient for the operation of success oriented organizations and we strive to be an indispensable element in their success.

Pernod Ricard is a convivial, responsible and successful global wine and spirits group and the #1 premium spirits organisation in the world. The Group represents 240 premium brands available in more than 160 countries. We are 18,500 exceptionally talented people worldwide with our own salesforce in 73 countries. Our portfolio is one of the most comprehensive in the market with every major category of wine and spirits, providing Pernod Ricard with a unique competitive advantage. To keep growing our business, transforming our industry and making a positive impact on the world, we believe in the power of human connection. Creating ‘convivialité’ is our business and our raison d’être. As ‘créateurs de convivialité’, our purpose is to turn every social interaction into a genuine, friendly and responsible experience of sharing. We believe there can be no convivialité with excess and strive to be sustainable and responsible at every step, from grain to glass.

We are an $8 billion sales and distribution organization that owns businesses brands focused on the global pulp, paper, tissue, packaging, wood products and metals industries. Our portfolio features a diverse array of products with one thing in common: All are used daily in businesses, homes and industries around the world. CNG is privately held and employs more than 3,000 people in 29 countries around the world, from customer service and sales to logistics and support teams. With a foundation of more than 136 years of family ownership, CNG offers market knowledge and adaptability to create value for our customers and suppliers worldwide. Visit our website to see a full list of our global locations and career opportunities.

For 45 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 760* high-quality generic, speciality and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 8 R&D centres and c9,100 employees worldwide. *As of February 2024 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

Ferring Pharmaceuticals is a privately owned, research-driven, specialty biopharmaceutical group committed to building families and helping people live better lives. We are leaders in reproductive medicine and maternal health, and in areas of gastroenterology and urology. We are at the forefront of innovation in microbiome-based therapeutics and uro-oncology intravesical gene therapy. Ferring was founded in 1950 and employs more than 7,000 people worldwide. The company is headquartered in Saint-Prex, Switzerland, and has operating subsidiaries in more than 50 countries which markets its medicines in over 100 countries. Community guidelines available here: https://re.ferring.com/Ferring-LinkedIn-Community-Guidelines Social Media Privacy Notice available here: https://www.ferring.com/social-media-privacy-notice/

We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO.

Headquartered in New York City, Axel Johnson Inc. is the corporate home for a collection of diverse industry-leading businesses. In 2018, Axel Johnson Inc. companies had revenues of approximately $4.6 billion, employed in excess of 4,000 people and served over 30,000 wholesale and trade customers. AJI is a private investment company, founded in 1920, and owned by the Johnson family of Stockholm, Sweden. Axel Johnson Inc. acquires and invests in companies to own and operate them, with the goal of building long-term enterprise value. Some of the companies in Axel Johnson Inc.’s portfolio have been part of the group for over 40 years. We take great pride in the companies that have chosen to be part of Axel Johnson Inc. and in the work they do every day. We, in turn, work hard each day to sustain the trust that the companies’ founders, owners, management and employees put in us at the time they joined us. We seek to create shareholder value and improve the world around us through the exercise of good business values. We are keenly aware that what we create, and how we conduct ourselves while doing so, is the legacy we leave behind.